The Medication Question: MAT, Psychiatric Medication, and the Stigma That Costs Lives

The Medication Question

The stigma surrounding medication in addiction recovery and mental health treatment is clinically costly. It shapes treatment decisions in ways that are inconsistent with the evidence and, in the case of opioid use disorder, produces preventable deaths.

Medication-assisted treatment (MAT) for opioid use disorder — using buprenorphine, methadone, or naltrexone — is among the most evidence-supported interventions in the behavioral health field. The research is consistent: MAT reduces overdose mortality, reduces illicit drug use, improves treatment retention, and improves social functioning. The effect sizes are large.

The Abstinence-Only Problem

A significant portion of the addiction treatment field remains committed to abstinence-only approaches that exclude or discourage MAT. This position is not supported by the evidence. It reflects a moral framework about what constitutes legitimate recovery rather than a clinical assessment of what produces the best outcomes.

For families navigating opioid use disorder, the abstinence-only framework is a clinical risk. Treatment programs that exclude MAT are offering a less effective intervention than the evidence supports. The decision to use or not use MAT should be made on clinical grounds, not ideological ones.

Psychiatric Medication in Recovery

The question of psychiatric medication in recovery is distinct from MAT but similarly complicated by stigma. Many individuals with substance use disorders have co-occurring psychiatric conditions — depression, anxiety, PTSD, bipolar disorder — that require pharmacological treatment. The untreated psychiatric condition is a relapse risk. Treating it with appropriate medication is a clinical necessity, not a compromise of recovery.

The interaction between psychiatric medication and recovery requires careful clinical management. Not all medications are appropriate in all recovery contexts. The management of this complexity requires a clinician who understands both addiction medicine and psychiatry.

Contact Coast Health Consulting to discuss medication management and integrated treatment planning.